Tactical Underweight: Trim 15-20% now, preserve 80-85% residual, pre-commit re-entry at $198.50 or $185-172
Three risk analysts converge on directional Underweight based on: (1) 14% post-backlog drawdown ($226 to $194) confirming bear thesis despite record $289B backlog visibility; (2) 0.29 beta making RTX a yield-proxy that gets sold as 10Y sits at 5% with 95% probability of zero 2026 Fed cuts; (3) fragile technical setup (negative MACD 13 sessions, negative divergence, ATR compression 29% from peak) describing distribution not capitulation. The 15-20% trim (not 30-40% per Research Manager) captures documented +0.0% to +0.5% alpha band per 9/17 reflection without floor-attenuation drag. HOLD rejected per 9/11 reflection: asymmetric risk of -5-15% to $186-170 versus +3-5% to $200 makes two-sided patience unacceptable. Full SELL rejected per 9/02 reflection: $289B backlog, FCF inflection $4.7B to $9.88B TTM, $8B annual deleveraging, and 1.49% dividend yield (2.6x FCF coverage) justify 80-85% residual compounding exposure.
| Position | Action |
|---|---|
| Current position size at $194 | Trim 15-20% of existing RTX exposure |
| Initial trim execution | Execute 50% of trim immediately at $194 |
| Price bounces toward $198-200 | Execute remaining 50% of trim over 2-3 sessions |
| Remaining 80-85% position at $188.50 | Hard stop - exit entire remaining position below $188.50 (below intraday low, below lower Bollinger Band) |
| Price rallies to $207-210 without volume confirmation | Do not add - this is overhead resistance, not an add zone |
| Price at $193-194 with broken momentum | Do not treat 200 SMA as automatic add zone without reversal confirmation |
RTX is a compelling BUY at $194 due to its record $289B backlog providing years of contracted revenue visibility, accelerating fundamentals with 14-28% growth metrics, oversold technical capitulation, defensive 0.29 beta profile, and 20-27% consensus analyst upside that has not been priced in.
| Indicator | Value | Signal |
|---|---|---|
| Price Close | $194.00 | neutral |
| 10 EMA | 197.43 | bearish |
| 50 SMA | 207.70 | bearish |
| 200 SMA | 192.97 | neutral |
| MACD | -4.50 | bearish |
| MACD Signal Line | -3.48 | bearish |
| MACD Histogram | -1.02 | bearish |
| RSI (14) | 31.01 | bullish |
| Bollinger Upper Band | 215.70 | neutral |
| Bollinger Middle Band | 202.46 | neutral |
| Bollinger Lower Band |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
EV: +20-27% · concedes: TTM P/E of 34.2x — acknowledged as a fair point; GTF inspection program is a risk — though already priced in; Tariff/FAA radar cost inflation cited by bear — though characterized as single-digit percent business/rounding error; No retail bid / silent community — though reframed as absence of euphoria at oversold levels
RTX is a "falling knife masquerading as a gift" at $194—the backlog is already public (stock dropped 14% despite it), the forward P/E of 24.7x requires perfection across all three segments, and the technical setup shows the 200 SMA held by only $1.03 with no capitulation buying, suggesting continued choppy consolidation or further downside in a macro regime that punishes premium multiples.
· concedes: The $289B backlog is genuinely remarkable; The deleveraging is real; The FCF profile is impressive; Q2 2026 GTF aftermarket numbers are encouraging; Dividends are growing modestly; The sentiment picture being 'ugly' could mean limited further downside if macro stabilizes
→ vs conservative: The 0.29 beta is not a defensive characteristic - it's a bond proxy that gets marked down when real rates rise in a 5 percent yield environment
→ vs conservative: The backlog is already a failed catalyst that the market voted against with a 14 percent drop on the news - waiting for it to matter again is hope, not analysis
→ vs conservative: The 24-month thesis is irrelevant in a regime with 95 percent odds of zero Fed cuts in 2026 and structurally rising cost of capital
→ vs neutral: Waiting for technical confirmation is not disciplined - it's carrying full directional risk without collecting premium, essentially short gamma with no compensation
→ vs neutral: The dead-cat bounce off the 200 SMA is not a stable base - it's distribution, and one bad macro print breaks it
→ vs neutral: The oversold RSI hasn't printed bullish divergence yet, meaning the technical relief rally has further to unwind
| 189.21 |
| bullish |
| ATR (14) | 4.02 | neutral |
| VWMA (20) | 198.51 | bearish |
| Volume | 9,734,012 | neutral |
Support: 189.21 · 192.97 · 197.43 · 198.51 | Resistance: 202.46 · 207.7 · 215.7 · 225.49
RTX is trading at $194.00 with the long-term 200 SMA ($192.97) as the last line of defense after a 22-session selloff from $226.41. Short-term momentum is bearish with MACD at -4.50 and RSI oversold at 31.01, but ATR compression (4.02, down 29% from peak) and a Bollinger lower band tag at $189.21 suggest selling exhaustion. The 50 SMA ($207.70) and VWMA ($198.51) represent key reclaim levels for bullish resolution; failure below $190-$191 opens downside to $186 and $170. Recommended action: HOLD pending resolution at the 200 SMA inflection point.
Market Cap
$261.47B
Market Cap
$261.47B
Implied Share Price
~$194
52-Week High
$226.88
52-Week Low
$155.64
50-Day Avg Price
$208.07
200-Day Avg Price
$194.04
Beta
0.287
Dividend Yield
1.51%
Shares Outstanding
~1.348B
P/E (TTM)
34.2x
Forward P/E
24.7x
PEG Ratio
2.28
Price / Book
3.94x
Book Value / Share
$49.25
EPS (TTM)
$5.67
Forward EPS
$7.85
Revenue (TTM)
$93.5B
Gross Profit (TTM)
$19.0B
Gross Margin
20.3%
EBITDA (TTM)
$15.9B
EBITDA Margin
17.0%
Operating Income (TTM)
$11.9B
Operating Margin
12.7%
Net Income (TTM)
$7.74B
Net Margin
8.3%
Free Cash Flow (TTM)
$9.88B
FCF Margin
10.6%
Q2 2026 Revenue
$24.71B
Q2 2026 Revenue YoY Growth
+14.5%
Q2 2026 Diluted EPS
$1.57
Q1 2026 Revenue
$22.08B
Q1 2026 Revenue YoY Growth
+9.0%
Q1 2026 Diluted EPS
$1.51
Q4 2025 Revenue
$24.24B
Q4 2025 Revenue YoY Growth
+12.4%
Q4 2025 Diluted EPS
$1.19
Q3 2025 Revenue
$22.48B
Q3 2025 Revenue YoY Growth
+10.6%
Q3 2025 Diluted EPS
$1.41
Q2 2025 Revenue
$21.58B
Q2 2025 Diluted EPS
$1.22
Total Assets
$174.0B
Total Liabilities
$105.8B
Stockholders' Equity
$66.4B
Total Debt
$38.9B
Cash & Equivalents
$8.3B
Net Debt
$29.1B
Current Ratio
1.011
Working Capital
$667M
Net Debt / EBITDA
~1.83x
Tangible Book Value
($17.6B)
Deferred Revenue (Current)
$22.7B
Deferred Revenue (Long-term)
$7.3B
Receivables
$32.9B
Inventory
$14.4B
Q2 2026 Operating Cash Flow
$3.55B
Q2 2026 CapEx
($727M)
Q2 2026 Free Cash Flow
$2.82B
Q2 2026 Dividends Paid
($983M)
Q2 2026 Net Debt Repayment
($24M)
Q1 2026 Free Cash Flow
$1.21B
Q4 2025 Free Cash Flow
$3.05B
Q3 2025 Free Cash Flow
$3.90B
Q2 2025 Free Cash Flow
($0.19B)
TTM Free Cash Flow
~$9.88B
FCF / Net Income Ratio
~128%
Dividends (Quarterly)
~$983M
Dividends (Annual)
~$3.93B
Payout Ratio
~50%
Buybacks
$0
ROE
12.3%
ROA
4.2%
Pension Obligations (Long-term)
~$2.0B
Pension Obligations (Current)
~$2.4B
Pension Expense
~$300M
R&D (Quarterly)
~$700M
Strengths
Concerns
RTX Corporation is a high-quality aerospace and defense conglomerate in active deleveraging, with TTM revenue of $93.5B, net debt reduced by ~$8B to $29.1B, and robust FCF of $9.88B representing 128% conversion of net income. The valuation is demanding on TTM metrics (P/E 34.2x) but reasonable on forward metrics (P/E 24.7x, Forward EPS $7.85), warranting a HOLD for current owners given the consolidation pattern but a BUY on meaningful pullbacks to the $185–190 zone or breakout above $215 with buyback resumption commentary. Key risks include GTF inspection program timing, defense budget volatility, pension obligations, and tight working capital; key catalysts include continued debt paydown milestones, Q3 2026 earnings, and resumption of share repurchases expected mid-2027.
Macro: 10Y Treasury yield hovering near 5% (multi-year high); Fed-cut odds essentially zero for 2026 (95% implied probability per Polymarket, $8.4M volume); markets pricing higher-for-longer regime. Broad risk-off backdrop with S&P 500 and Dow posting weekly losses. Soft landing consensus holds with only 8% recession probability for end-2026. Geopolitical tensions elevated (Iran war ongoing, JPMorgan dropped forecast); defense budget continuity under watch amid Congress fiscal uncertainty.